CoChat

Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies

Open access
Forrest, Shelley L, Kril, Jillian J, Stevens, Claire H, Kwok, John B, Hallupp, Marianne, Kim, Woojin S, Huang, Yue, McGinley, Ciara V, Werka, Hellen, Kiernan, Matthew C, Götz, Jürgen, Spillantini, Maria Grazia, Hodges, John R, Ittner, Lars M, Halliday, Glenda M · 2018 · Brain
Cited by 148

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

See Josephs (doi:10.1093/brain/awx367) for a scientific commentary on this article.In many neurodegenerative disorders, familial forms have provided important insights into the pathogenesis of their corresponding sporadic forms. The first mutations associated with frontotemporal lobar degeneration (FTLD) were found in the microtubule-associated protein tau (MAPT) gene on chromosome 17 in families with frontotemporal degeneration and parkinsonism (FTDP-17). However, it was soon discovered that 50% of these families had a nearby mutation in progranulin. Regardless, the original FTDP-17 nomenclature has been retained for patients with MAPT mutations, with such patients currently classified independently from the different sporadic forms of FTLD with tau-immunoreactive inclusions (FTLD-tau). The separate classification of familial FTLD with MAPT mutations implies that familial forms cannot inform on the pathogenesis of the different sporadic forms of FTLD-tau. To test this assumption, this study pathologically assessed all FTLD-tau cases with a known MAPT mutation held by the Sydney and Cambridge Brain Banks, and compared them to four cases of four subtypes of sporadic FTLD-tau, in addition to published case reports. Ten FTLD-tau cases with a MAPT mutation (K257T, S305S, P301L, IVS10+16, R406W) were screened for the core differentiating neuropathological features used to diagnose the different sporadic FTLD-tau subtypes to determine whether the categorical separation of MAPT mutations from sporadic FTLD-tau is valid. Compared with sporadic cases, FTLD-tau cases with MAPT mutations had similar mean disease duration but were younger at age of symptom onset (55 ± 4 years versus 70 ± 6 years). Interestingly, FTLD-tau cases with MAPT mutations had similar patterns and severity of neuropathological features to sporadic FTLD-tau subtypes and could be classified into: Pick's disease (K257T), corticobasal degeneration (S305S, IVS10‰+‰16, R406W), progressive supranuclear palsy (S305S) or globular glial tauopathy (P301L, IVS10‰+‰16). The finding that the S305S mutation could be classified into two tauopathies suggests additional modifying factors. Assessment of our cases and previous reports suggests that distinct MAPT mutations result in particular FTLD-tau subtypes, supporting the concept that they are likely to inform on the varied cellular mechanisms involved in distinctive forms of sporadic FTLD-tau. As such, FTLD-tau cases with MAPT mutations should be considered familial forms of FTLD-tau subtypes rather than a separate FTDP-17 category, and continued research on the effects of different mutations more focused on modelling their impact to produce the very different sporadic FTLD-tau pathologies in animal and cellular models.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awx328

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 87

  1. Ahmed, 2013, Globular glial tauopathies (GGT): consensus recommendations, Acta Neuropathol, 126, 537, 10.1007/s00401-013-1171-0 · DOI · Paper page
  2. Allen, 2016, Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci, Acta Neuropathol, 132, 197, 10.1007/s00401-016-1576-7 · DOI · Paper page
  3. Anfossi, 2011, Compound heterozygosity of 2 novel MAPT mutations in frontotemporal dementia, Neurobiol Aging, 32, 757e1, 10.1016/j.neurobiolaging.2010.12.013 · DOI
  4. Aoyagi, 2007, Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau, J Biol Chem, 282, 20309, 10.1074/jbc.M611876200 · DOI · Paper page
  5. Boeve, 2011, The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study, J Mol Neurosci, 45, 350, 10.1007/s12031-011-9624-1 · DOI
  6. Borroni, 2010, VEGF haplotypes are associated with increased risk to progressive supranuclear palsy and corticobasal syndrome, J Alzheimers Dis, 21, 87, 10.3233/JAD-2010-091615 · DOI
  7. Bronner, 2005, Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology, Brain, 128, 2645, 10.1093/brain/awh591 · DOI · Paper page
  8. Burrell, 2016, Expanding the phenotypic associations of globular glial tau subtypes, Alzheimers Dement, 4, 6
  9. Chahine, 2014, Corticobasal syndrome: Five new things, Neurol Clin Pract, 4, 304, 10.1212/CPJ.0000000000000026 · DOI
  10. Chaunu, 2013, Juvenile frontotemporal dementia with parkinsonism associated with tau mutation G389R, J Alzheimers Dis, 37, 769, 10.3233/JAD-130413 · DOI
  11. Chiu, 2010, Survival in progressive supranuclear palsy and frontotemporal dementia, J Neurol Neurosurg Psychiatry, 81, 441, 10.1136/jnnp.2009.195719 · DOI · Paper page
  12. D'Souza, 2006, Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K, J Biol Chem, 281, 2460, 10.1074/jbc.M505809200 · DOI · Paper page
  13. de Yebenes, 1995, Familial progressive supranuclear palsy. Description of a pedigree and review of the literature, Brain, 118, 1095, 10.1093/brain/118.5.1095 · DOI · Paper page
  14. Delisle, 1999, A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy, Acta Neuropathol, 98, 62, 10.1007/s004010051052 · DOI · Paper page
  15. Deramecourt, 2012, Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S, J Alzheimers Dis, 31, 741, 10.3233/JAD-2012-120160 · DOI · Paper page
  16. Domoto-Reilly, 2017, Unusually long duration and delayed penetrance in a family with FTD and mutation in MAPT (V337M), Am J Med Genet B Neuropsychiatr Genet, 174, 70, 10.1002/ajmg.b.32443 · DOI
  17. Donker Kaat, 2009, Familial aggregation of parkinsonism in progressive supranuclear palsy, Neurology, 73, 98, 10.1212/WNL.0b013e3181a92bcc · DOI · Paper page
  18. Ferrari, 2014, Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy, Neurobiol Aging, 35, 1514 e1, 10.1016/j.neurobiolaging.2014.01.010 · DOI
  19. Ferrer, 2014, Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression, J Neuropathol Exp Neurol, 73, 81, 10.1097/NEN.0000000000000030 · DOI · Paper page
  20. Fujioka, 2015, Three sib-pairs of autopsy-confirmed progressive supranuclear palsy, Parkinsonism Relat Disord, 21, 101, 10.1016/j.parkreldis.2014.10.028 · DOI · Paper page
  21. Gasca-Salas, 2016, Characterization of movement disorder phenomenology in genetically proven, familial frontotemporal lobar degeneration: a systematic review and meta-analysis, PLoS One, 11, e0153852, 10.1371/journal.pone.0153852 · DOI
  22. Gauthier-Kemper, 2011, The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner, J Cell Biol, 192, 647, 10.1083/jcb.201007161 · DOI · Paper page
  23. Ghetti, 2000, Progress in hereditary tauopathies: a mutation in the Tau gene (G389R) causes a Pick disease-like syndrome, Ann N Y Acad Sci, 920, 52, 10.1111/j.1749-6632.2000.tb06905.x · DOI
  24. Ghetti, 2015, Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging, Neuropathol Appl Neurobiol, 41, 24, 10.1111/nan.12213 · DOI · Paper page
  25. Goldman, 2005, Comparison of family histories in FTLD subtypes and related tauopathies, Neurology, 65, 1817, 10.1212/01.wnl.0000187068.92184.63 · DOI · Paper page
  26. Grijalvo-Perez, 2014, Corticobasal degeneration, Semin Neurol, 34, 160, 10.1055/s-0034-1381734 · DOI
  27. Gunawardana, 2015, The human tau interactome: binding to the ribonucleoproteome, and impaired binding of the proline-to-leucine mutant at position 301 (P301L) to chaperones and the proteasome, Mol Cell Proteomics, 14, 3000, 10.1074/mcp.M115.050724 · DOI · Paper page
  28. Halliday, 2006, Neuropathology in the S305S tau gene mutation, Brain, 129, E40, 10.1093/brain/awh720 · DOI
  29. Hauw, 1994, Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy), Neurology, 44, 2015, 10.1212/WNL.44.11.2015 · DOI · Paper page
  30. Hayashi, 2002, Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation, Ann Neurol, 51, 525, 10.1002/ana.10163 · DOI · Paper page
  31. Hodges, 2003, Survival in frontotemporal dementia, Neurology, 61, 349, 10.1212/01.WNL.0000078928.20107.52 · DOI · Paper page
  32. Hogg, 2003, The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy, Acta Neuropathol, 106, 323, 10.1007/s00401-003-0734-x · DOI
  33. Hoglinger, 2011, Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy, Nat Genet, 43, 699, 10.1038/ng.859 · DOI · Paper page
  34. Irwin, 2016, Deep clinical and neuropathological phenotyping of Pick disease, Ann Neurol, 79, 272, 10.1002/ana.24559 · DOI · Paper page
  35. Ittner, 2008, Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia, Proc Natl Acad Sci USA, 105, 15997, 10.1073/pnas.0808084105 · DOI · Paper page
  36. Ittner, 2015, FTD and ALS–translating mouse studies into clinical trials, Nat Rev Neurol, 11, 360, 10.1038/nrneurol.2015.65 · DOI · Paper page
  37. Jellinger, 2007, Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease, Acta Neuropathol, 113, 107, 10.1007/s00401-006-0156-7 · DOI
  38. Jiang, 2003, Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta, J Biol Chem, 278, 18997, 10.1074/jbc.M301800200 · DOI · Paper page
  39. Josephs, 2011, Neuropathological background of phenotypical variability in frontotemporal dementia, Acta Neuropathol, 122, 137, 10.1007/s00401-011-0839-6 · DOI · Paper page
  40. Jung, 2012, Phenotypic variation of autosomal-dominant corticobasal degeneration, Eur Neurol, 67, 142, 10.1159/000334731 · DOI
  41. Katsuse, 2003, 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy, Acta Neuropathol, 106, 251, 10.1007/s00401-003-0728-8 · DOI
  42. Kondo, 2004, Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA, Genes Cells, 9, 121, 10.1111/j.1356-9597.2004.00709.x · DOI · Paper page
  43. Kouri, 2011, Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome, Brain, 134, 3264, 10.1093/brain/awr234 · DOI · Paper page
  44. Kouri, 2014, Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration, Acta Neuropathol, 127, 271, 10.1007/s00401-013-1193-7 · DOI · Paper page
  45. Kovacs, 2008, MAPT S305I mutation: implications for argyrophilic grain disease, Acta Neuropathol, 116, 103, 10.1007/s00401-007-0322-6 · DOI
  46. Kovacs, 2013, Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium, Neuropathol Appl Neurobiol, 39, 166, 10.1111/j.1365-2990.2012.01272.x · DOI · Paper page
  47. Lang, 2003, Corticobasal degeneration: selected developments, Mov Disord, 18 Suppl 6, S51, 10.1002/mds.10563 · DOI
  48. Lashley, 2015, An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations, Neuropathol Appl Neurobiol, 41, 858, 10.1111/nan.12250 · DOI · Paper page
  49. Le Ber, 2013, C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing, J Alzheimers Dis, 34, 485, 10.3233/JAD-121456 · DOI · Paper page
  50. Lee, 2017, Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration, Acta Neuropathol, 134, 65, 10.1007/s00401-017-1679-9 · DOI · Paper page
  51. Lippa, 2000, Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation, Ann Neurol, 48, 850, 10.1002/1531-8249(200012)48:6<850::AID-ANA5>3.0.CO;2-V · doi:10.1002/1531-8249(200012)48:6<850::aid-ana5>3.0.co;2-v
  52. Maltete, 2016, Adult-onset stereotypical motor behaviors, Rev Neurol, 172, 477, 10.1016/j.neurol.2016.07.002 · DOI
  53. Morris, 2003, Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP, Neurology, 61, 102, 10.1212/01.WNL.0000072325.27824.A5 · DOI · Paper page
  54. Murrell, 1999, Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits, J Neuropathol Exp Neurol, 58, 1207, 10.1097/00005072-199912000-00002 · DOI · Paper page
  55. Neumann, 2001, Pick's disease associated with the novel Tau gene mutation K369I, Ann Neurol, 50, 503, 10.1002/ana.1223 · DOI · Paper page
  56. Ouchi, 2014, Pathology and sensitivity of current clinical criteria in corticobasal syndrome, Mov Disord, 29, 238, 10.1002/mds.25746 · DOI
  57. Pickering-Brown, 2000, Pick's disease is associated with mutations in the tau gene, Ann Neurol, 48, 859, 10.1002/1531-8249(200012)48:6<859::AID-ANA6>3.0.CO;2-1 · doi:10.1002/1531-8249(200012)48:6<859::aid-ana6>3.0.co;2-1
  58. Pickering-Brown, 2004, Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene, Brain, 127, 1415, 10.1093/brain/awh147 · DOI · Paper page
  59. Piguet, 2011, Clinical phenotypes in autopsy-confirmed Pick disease, Neurology, 76, 253, 10.1212/WNL.0b013e318207b1ce · DOI · Paper page
  60. Po, 2014, Heritability in frontotemporal dementia: more missing pieces?, J Neurol, 261, 2170, 10.1007/s00415-014-7474-9 · DOI
  61. Poorkaj, 2002, An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype, Ann Neurol, 52, 511, 10.1002/ana.10340 · DOI · Paper page
  62. Rademakers, 2013, Advances in understanding the molecular basis of frontotemporal dementia, Nature Rev Neurol, 9, 240, 10.1038/nrneurol.2013.76 · DOI
  63. Reed, 2001, Phenotypic correlations in FTDP-17, Neurobiol Aging, 22, 89, 10.1016/S0197-4580(00)00202-5 · DOI · Paper page
  64. Rizzini, 2000, Tau gene mutation K257T causes a tauopathy similar to Pick's disease, J Neuropathol Exp Neurol, 59, 990, 10.1093/jnen/59.11.990 · DOI · Paper page
  65. Rohrer, 2011, Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration, Brain, 134, 2565, 10.1093/brain/awr198 · DOI · Paper page
  66. Rojo, 1999, Clinical genetics of familial progressive supranuclear palsy, Brain, 122, 1233, 10.1093/brain/122.7.1233 · DOI · Paper page
  67. Ros, 2005, A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy, Arch Neurol, 62, 1444, 10.1001/archneur.62.9.1444 · DOI · Paper page
  68. Ros, 2008, Parkin polymorphisms in progressive supranuclear palsy, J Neurol Sci, 268, 176, 10.1016/j.jns.2007.10.022 · DOI
  69. Rosso, 2002, A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease, Ann Neurol, 51, 373, 10.1002/ana.10140 · DOI · Paper page
  70. Sanchez, 2002, Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin mutation, J Alzheimers Dis, 4, 399, 10.3233/JAD-2002-4506 · DOI
  71. Scaravilli, 2005, Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting, Mov Disord, 20 Suppl 12, S21, 10.1002/mds.20536 · DOI · Paper page
  72. Schellenberg, 2012, The genetics and neuropathology of Alzheimer's disease, Acta Neuropathol, 124, 305, 10.1007/s00401-012-0996-2 · DOI · Paper page
  73. Skoglund, 2008, The tau S305S mutation causes frontotemporal dementia with parkinsonism, Eur J Neurol, 15, 156, 10.1111/j.1468-1331.2007.02017.x · DOI · Paper page
  74. Stanford, 2000, Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations, Brain, 123, 880, 10.1093/brain/123.5.880 · DOI · Paper page
  75. Tacik, 2015, A novel tau mutation in exon 12, p.Q336H, causes hereditary Pick disease, J Neuropathol Exp Neurol, 74, 1042, 10.1097/NEN.0000000000000248 · DOI · Paper page
  76. Tacik, 2015, A novel tau mutation, p.K317N, causes globular glial tauopathy, Acta Neuropathol, 130, 199, 10.1007/s00401-015-1425-0 · DOI · Paper page
  77. Tacik, 2017, FTDP-17 with pick body-like inclusions associated with a novel tau mutation, p.E372G, Brain Pathol, 27, 612, 10.1111/bpa.12428 · DOI
  78. Tacik, 2017, Clinicopathologic heterogeneity in FTDP-17 due to MAPT p.P301L mutation, including a patient with globular glial tauopathy, Neuropathol Appl Neurobiol, 43, 200, 10.1111/nan.12367 · DOI · Paper page
  79. Tan, 2005, Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration?, Acta Neuropathol, 109, 329, 10.1007/s00401-004-0933-0 · DOI
  80. Tuite, 2005, Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy, Arch Neurol, 62, 1453, 10.1001/archneur.62.9.1453 · DOI
  81. Van Deerlin, 2007, Biochemical and pathological characterization of frontotemporal dementia due to a Leu266Val mutation in microtubule-associated protein tau in an African American individual, Acta Neuropathol, 113, 471, 10.1007/s00401-006-0155-8 · DOI
  82. van Herpen, 2003, Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R, Ann Neurol, 54, 573, 10.1002/ana.10721 · DOI · Paper page
  83. van Swieten, 2007, Hereditary frontotemporal dementia caused by Tau gene mutations, Brain Pathol, 17, 63, 10.1111/j.1750-3639.2007.00052.x · DOI · Paper page
  84. van Swieten, 1999, Phenotypic variation in hereditary frontotemporal dementia with tau mutations, Ann Neurol, 46, 617, 10.1002/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I · doi:10.1002/1531-8249(199910)46:4<617::aid-ana10>3.0.co;2-i
  85. van Swieten, 2007, The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo, J Neuropathol Exp Neurol, 66, 17, 10.1097/nen.0b013e31802c39a4 · DOI · Paper page
  86. Vanacore, 2001, Epidemiology of progressive supranuclear palsy, European Study Group on Atypical Parkinsonisms. Neurol Sci, 22, 101
  87. Yokota, 2009, Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions, Acta Neuropathol, 117, 429, 10.1007/s00401-009-0493-4 · DOI

Cited by

See all 148

Metadata

Authors
Forrest, S. L., Kril, J. J., Stevens, C. H., Kwok, J. B., Hallupp, M., Kim, W. S., Huang, Y., McGinley, C. V., Werka, H., Kiernan, M. C., Götz, J., Spillantini, M. G., Hodges, J. R., Ittner, L. M., & Halliday, G. M.
Venue
Brain
Published
2017-12-14
Volume
141
Issue
2
Pages
521-534
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2775738646
Cited by
148
References
24
FWCI
10.82
Type
journal article
Language
en
Open access
hybrid
Funders
University of New South Wales

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.